Newsroom
January 12, 2021
Dr. Barbara Taylor, Infectious Diseases, was interviewed about the launch of the Novavax vaccine clinical trial at UT Health San Antonio and clinical partner University Health. 500 San Antonians are needed for this two-year COVID-19 vaccine study. Read the story.
January 12, 2021
Dr. Barbara Taylor, Infectious Diseases, was interviewed about the launch of the Novavax vaccine clinical trial at UT Health San Antonio and clinical partner University Health. 500 San Antonians are needed for this two-year COVID-19 vaccine study. Read the story.
January 12, 2021
Dr. Barbara Taylor, Infectious Diseases, contributed to this second KENS 5 TV news segment on the Novavax trial launch, emphasizing that minorities are desperately needed for clinical trials because the inclusion of diverse groups in trials is the only way to make effective vaccines for all. Read and watch the story.
January 11, 2021
Dr. Gabriel de Erausquin and Dr. Sudha Seshadri, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and their work on the long-term effects of COVID-19 on the brain, were featured in the Jan. 18 printed edition of the San Antonio Express-News. Read the story.
January 11, 2021
Dr. Jason Bowling, Infectious Diseases, spoke to KENS 5 TV viewers about the recent study that suggests the Pfizer vaccine is effective against coronavirus variants. Read and watch the story.
January 11, 2021
Dr. Robert Leverence, chief medical officer for UT Health Physicians, contributed to a KENS 5 story that was propagated by MSN regarding helpful information as our city prepares for mass vaccinations, as well as on the topic of someone’s getting COVID between the administration of the first and second doses of the vaccine. Read and […]